Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Medhat Faris"'
Autor:
AR Jazieh on Behalf of Saudi Lung Cancer Guidelines Association - Saudi Lung Cancer Guidelines Members, Abdul Rahman Jazieh, Khaled Al Kattan, Ahmed Bamousa, Ashwaq Al Olayan, Ahmed Abdelwarith, Jawaher Ansari, Abdullah Al Twairqi, Turki Al Fayea, Khalid Al Saleh, Hamed Al Husaini, Nafisa Abdelhafiez, Mervat Mahrous, Medhat Faris, Ameen Al Omair, Adnan Hebshi, Salem Al Shehri, Foad Al Dayel, Hanaa Bamefleh, Walid Khalbuss, Sarah Al Ghanem, Shukri Loutfi, Azzam Khankan, Meshael Al Rujaib, Majed Al Ghamdi, Nagwa Ibrahim, Abdulmonem Swied, Mohammad Al Kayait, Marie Datario
Publikováno v:
Annals of Thoracic Medicine, Vol 12, Iss 4, Pp 221-246 (2017)
Background: Lung cancer management is getting more complex due to the rapid advances in all aspects of diagnostic and therapeutic options. Developing guidelines is critical to help practitioners provide standard of care. Methods: The Saudi Lung Cance
Externí odkaz:
https://doaj.org/article/e8594a6a4fef4da98db83ae6dca46ab7
Autor:
Omalkhair Abulkhair, Mohammed Al Balwi, Ola Makram, Lamia Alsubaie, Medhat Faris, Hussam Shehata, Ahmed Hashim, Banu Arun, Ahmed Saadeddin, Ezzeldin Ibrahim
Publikováno v:
Journal of Global Oncology, Vol 4 (2018)
Purpose: Over the past three decades, the incidence rate of breast cancer (BC) among Arab women has continually increased. However, data on the prevalence of BRCA1/2 mutations are scarce. Although the population in Saudi Arabia is at large homogeneou
Externí odkaz:
https://doaj.org/article/57e7d38210594c53aee612afb1da7234
Autor:
AbdulRahman Jazieh, null AR Jazieh, Khaled Al Kattan, Ahmed Bamousa, Ashwaq Al Olayan, Ahmed Abdelwarith, Jawaher Ansari, Abdullah Al Twairqi, Turki Al Fayea, Khalid Al Saleh, Hamed Al Husaini, Nafisa Abdelhafiez, Mervat Mahrous, Medhat Faris, Ameen Al Omair, Adnan Hebshi, Salem Al Shehri, Foad Al Dayel, Hanaa Bamefleh, Walid Khalbuss, Sarah Al Ghanem, Shukri Loutfi, Azzam Khankan, Meshael Al Rujaib, Majed Al Ghamdi, Nagwa Ibrahim, Abdulmonem Swied, Mohammad Al Kayait, Marie Datario
Publikováno v:
Annals of Thoracic Medicine, Vol 12, Iss 4, Pp 221-246 (2017)
Annals of Thoracic Medicine
Annals of Thoracic Medicine
Background: Lung cancer management is getting more complex due to the rapid advances in all aspects of diagnostic and therapeutic options. Developing guidelines is critical to help practitioners provide standard of care. Methods: The Saudi Lung Cance
Autor:
Ezzeldin Ibrahim, Banu Arun, Medhat Faris, Ahmed Hashim, Ahmed Saadeddin, Lamia Alsubaie, Omalkhair Abulkhair, Ola Makram, Hussam Shehata, Mohammed Al Balwi
Publikováno v:
Journal of Global Oncology
Journal of Global Oncology, Vol 4 (2018)
Journal of Global Oncology, Vol 4 (2018)
Purpose Over the past three decades, the incidence rate of breast cancer (BC) among Arab women has continually increased. However, data on the prevalence of BRCA1/2 mutations are scarce. Although the population in Saudi Arabia is at large homogeneous
Autor:
Medhat Faris, Hani Hassan Alhashmi, Fahd Saad Ibnshamsah, Ehab Ahmed Ibrahim, Hossam Ragab Mohammad Abdulkhalek
Publikováno v:
Journal of Clinical Oncology. 36:e18837-e18837
e18837Background: Chemotherapy-induced febrile neutropenia is a serious side effect of cancer treatment. Recombinant human granulocyte colony stimulating factor (G-CSF) is the only agent currently ...
Autor:
Medhat Faris
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 11(1)
A prospective study was carried out in the only tertiary oncology department in Oman to analyse the pattern of various prognostic factors in terminally ill cancer patients and their impact on these patients. Between September 1999 and February 2001,
Autor:
Abulkhair O; Omalkhair Abulkhair, Specialized Medical Center; Mohammed Al Balwi, Ola Makram, Lamia Alsubaie, Hussam Shehata, Ahmed Hashim, and Ahmed Saadeddin, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh; Medhat Faris, King Fahad Specialist Hospital, Dammam; Ezzeldin Ibrahim, Oncology Center of Excellence, International Medical Center, Jeddah, Kingdom of Saudi Arabia; and Banu Arun, The University of Texas MD Anderson Cancer Center, Houston, TX., Al Balwi M; Omalkhair Abulkhair, Specialized Medical Center; Mohammed Al Balwi, Ola Makram, Lamia Alsubaie, Hussam Shehata, Ahmed Hashim, and Ahmed Saadeddin, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh; Medhat Faris, King Fahad Specialist Hospital, Dammam; Ezzeldin Ibrahim, Oncology Center of Excellence, International Medical Center, Jeddah, Kingdom of Saudi Arabia; and Banu Arun, The University of Texas MD Anderson Cancer Center, Houston, TX., Makram O; Omalkhair Abulkhair, Specialized Medical Center; Mohammed Al Balwi, Ola Makram, Lamia Alsubaie, Hussam Shehata, Ahmed Hashim, and Ahmed Saadeddin, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh; Medhat Faris, King Fahad Specialist Hospital, Dammam; Ezzeldin Ibrahim, Oncology Center of Excellence, International Medical Center, Jeddah, Kingdom of Saudi Arabia; and Banu Arun, The University of Texas MD Anderson Cancer Center, Houston, TX., Alsubaie L; Omalkhair Abulkhair, Specialized Medical Center; Mohammed Al Balwi, Ola Makram, Lamia Alsubaie, Hussam Shehata, Ahmed Hashim, and Ahmed Saadeddin, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh; Medhat Faris, King Fahad Specialist Hospital, Dammam; Ezzeldin Ibrahim, Oncology Center of Excellence, International Medical Center, Jeddah, Kingdom of Saudi Arabia; and Banu Arun, The University of Texas MD Anderson Cancer Center, Houston, TX., Faris M; Omalkhair Abulkhair, Specialized Medical Center; Mohammed Al Balwi, Ola Makram, Lamia Alsubaie, Hussam Shehata, Ahmed Hashim, and Ahmed Saadeddin, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh; Medhat Faris, King Fahad Specialist Hospital, Dammam; Ezzeldin Ibrahim, Oncology Center of Excellence, International Medical Center, Jeddah, Kingdom of Saudi Arabia; and Banu Arun, The University of Texas MD Anderson Cancer Center, Houston, TX., Shehata H; Omalkhair Abulkhair, Specialized Medical Center; Mohammed Al Balwi, Ola Makram, Lamia Alsubaie, Hussam Shehata, Ahmed Hashim, and Ahmed Saadeddin, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh; Medhat Faris, King Fahad Specialist Hospital, Dammam; Ezzeldin Ibrahim, Oncology Center of Excellence, International Medical Center, Jeddah, Kingdom of Saudi Arabia; and Banu Arun, The University of Texas MD Anderson Cancer Center, Houston, TX., Hashim A; Omalkhair Abulkhair, Specialized Medical Center; Mohammed Al Balwi, Ola Makram, Lamia Alsubaie, Hussam Shehata, Ahmed Hashim, and Ahmed Saadeddin, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh; Medhat Faris, King Fahad Specialist Hospital, Dammam; Ezzeldin Ibrahim, Oncology Center of Excellence, International Medical Center, Jeddah, Kingdom of Saudi Arabia; and Banu Arun, The University of Texas MD Anderson Cancer Center, Houston, TX., Arun B; Omalkhair Abulkhair, Specialized Medical Center; Mohammed Al Balwi, Ola Makram, Lamia Alsubaie, Hussam Shehata, Ahmed Hashim, and Ahmed Saadeddin, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh; Medhat Faris, King Fahad Specialist Hospital, Dammam; Ezzeldin Ibrahim, Oncology Center of Excellence, International Medical Center, Jeddah, Kingdom of Saudi Arabia; and Banu Arun, The University of Texas MD Anderson Cancer Center, Houston, TX., Saadeddin A; Omalkhair Abulkhair, Specialized Medical Center; Mohammed Al Balwi, Ola Makram, Lamia Alsubaie, Hussam Shehata, Ahmed Hashim, and Ahmed Saadeddin, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh; Medhat Faris, King Fahad Specialist Hospital, Dammam; Ezzeldin Ibrahim, Oncology Center of Excellence, International Medical Center, Jeddah, Kingdom of Saudi Arabia; and Banu Arun, The University of Texas MD Anderson Cancer Center, Houston, TX., Ibrahim E; Omalkhair Abulkhair, Specialized Medical Center; Mohammed Al Balwi, Ola Makram, Lamia Alsubaie, Hussam Shehata, Ahmed Hashim, and Ahmed Saadeddin, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs; Mohammed Al Balwi, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh; Medhat Faris, King Fahad Specialist Hospital, Dammam; Ezzeldin Ibrahim, Oncology Center of Excellence, International Medical Center, Jeddah, Kingdom of Saudi Arabia; and Banu Arun, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Journal of global oncology [J Glob Oncol] 2018 Aug; Vol. 4, pp. 1-9.